KRISTEN EWING: Open Payments
NPI 1811431786 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 12 payments from 8 companies in 2025. Trend: 2023 $18 · 2024 $397 · 2025 $238
Food & beverage: $204Education: $34
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| GENZYME CORPORATION | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: TEZSPIRE, EOHILIA, DUPIXENT, NEFFY, Rhapsido, TRELEGY ELLIPTA, BREZTRI.
Industry payments across IN — which companies pay providers there.
